Stéphane Dalle Selected Research

Stéphane Dalle Research Topics

Disease

73	Melanoma (Melanoma, Malignant) 03/2024 - 02/2006
36	Neoplasms (Cancer) 12/2023 - 02/2006
13	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2016
11	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2002
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2023 - 03/2014
4	Obesity 01/2022 - 10/2014
4	Insulin Resistance 10/2019 - 02/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 02/2007
4	Lymphoma (Lymphomas) 01/2016 - 01/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023 - 01/2015
3	Hyperglycemia 01/2023 - 01/2018
3	Mycosis Fungoides 01/2023 - 01/2008
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2004
3	Lymphatic Metastasis 11/2020 - 03/2016
2	Cardiotoxicity 12/2023 - 01/2022
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2023 - 01/2015
2	Panniculitis 01/2023 - 04/2013
2	Inflammation (Inflammations) 08/2022 - 01/2022
2	Diabetes Mellitus 12/2019 - 04/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 04/2019
2	Pure Red-Cell Aplasia 01/2019 - 01/2019
1	Pain (Aches) 02/2024
1	Hepatitis 06/2023
1	Drug-Related Side Effects and Adverse Reactions 05/2023
1	Amyloid Plaque 01/2023
1	Lipodystrophy 01/2023
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2023
1	type 1 Autoimmune polyendocrinopathy syndrome 01/2023

Drug/Important Bio-Agent (IBA)

18	pembrolizumabIBA 02/2024 - 02/2017
16	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2016
14	NivolumabIBA 10/2023 - 11/2017
13	IpilimumabIBA 10/2023 - 09/2012
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2017
6	B7-H1 AntigenIBA 01/2023 - 11/2019
6	Rituximab (Mabthera)FDA Link 01/2018 - 02/2007
5	AntibodiesIBA 12/2023 - 01/2014
5	CytokinesIBA 01/2023 - 03/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2008
5	Insulin (Novolin)FDA Link 01/2021 - 07/2006
5	VemurafenibIBA 05/2017 - 10/2011
4	Zinc Finger E-box-Binding Homeobox 1IBA 03/2024 - 10/2016
4	Peptides (Polypeptides)IBA 01/2023 - 02/2002
4	Monoclonal AntibodiesIBA 01/2022 - 05/2009
3	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2022
3	Programmed Cell Death 1 ReceptorIBA 11/2023 - 10/2020
3	relatlimabIBA 04/2023 - 01/2022
3	mogamulizumabIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 03/2011
3	glucagon (19-29)IBA 10/2014 - 02/2002
2	SphingolipidsIBA 12/2023 - 01/2019
2	EnzymesIBA 12/2023 - 01/2020
2	LigandsIBA 01/2023 - 05/2018
2	AutoantibodiesIBA 01/2023 - 04/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	InterferonsIBA 01/2022 - 01/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2008
2	CateninsIBA 01/2022 - 01/2022
2	Chemokine ReceptorsIBA 08/2016 - 03/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 05/2016 - 01/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 01/2006
2	Glucagon (Glukagon)FDA Link 10/2014 - 02/2005
2	Bexarotene (LGD1069)FDA Link 06/2014 - 01/2008
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2014 - 02/2013
2	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2014 - 02/2013
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2012 - 07/2008
1	Phosphotransferases (Kinase)IBA 02/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2024
1	Cadherins (E-Cadherin)IBA 12/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 12/2023
1	Small Cytoplasmic RNAIBA 12/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023
1	cemiplimabIBA 10/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023
1	Brentuximab VedotinIBA 07/2023
1	Prednisolone (Predate)FDA LinkGeneric 07/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023
1	Alkaline PhosphataseIBA 06/2023
1	Alanine Transaminase (SGPT)IBA 06/2023
1	C-Reactive ProteinIBA 01/2023
1	PolyphenolsIBA 01/2023
1	VenomsIBA 01/2023
1	Perilipin-1IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	AlkaloidsIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ProteomeIBA 01/2023

Therapy/Procedure

38	Therapeutics 03/2024 - 02/2006
13	Immunotherapy 01/2024 - 01/2016
4	Drug Therapy (Chemotherapy) 01/2023 - 03/2009
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2019
3	Radiotherapy 01/2019 - 01/2004
2	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 05/2014
1	Homologous Transplantation 10/2023
1	Precision Medicine 01/2023
1	Glycemic Control 01/2023